The role of SGLT2 inhibitors beyond glucose-lowering to cardio-renal protection
People with type 2 diabetes mellitus (T2DM) are at high risk of developing cardiovascular disease (CVD) and kidney disease. This enhanced cardio-renal risk persists despite improvements in care and treatments over the last 20 years. Intensive glucose control alone does not substantially reduce the r...
| প্রধান লেখক: | |
|---|---|
| বিন্যাস: | প্রবন্ধ |
| ভাষা: | Russian |
| প্রকাশিত: |
«FIRMA «SILICEA» LLC
2021-04-01
|
| মালা: | Российский кардиологический журнал |
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | https://russjcardiol.elpub.ru/jour/article/view/4323 |